Skip to main content
SpringerLink
Log in

Renovascular Hypertension

  • Chapter
  • First Online:
Vascular Surgery

  • 1320 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kalra PA, Guo H, Kausz AT, et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005;68(1):293–301.

    Article  PubMed  Google Scholar 

  2. Gray BH, Olin JW, Childs MB, Sullivan TM, Bacharach JM. Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure. Vasc Med. 2002;7(4):275–9.

    Article  PubMed  Google Scholar 

  3. Zeller T, Muller C, Frank U, et al. Survival after stenting of severe atherosclerotic ostial renal artery stenoses. J Endovasc Ther. 2003;10(3):539–45.

    PubMed  Google Scholar 

  4. Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992;2(11):1608–16.

    CAS  PubMed  Google Scholar 

  5. Conlon PJ, Little MA, Pieper K, Mark DB. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001;60(4):1490–7.

    Article  CAS  PubMed  Google Scholar 

  6. Missouris CG, Buckenham T, Cappuccio FP, MacGregor GA. Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am J Med. 1994;96(1):10–4.

    Article  CAS  PubMed  Google Scholar 

  7. Derkx FH, Schalekamp MA. Renal artery stenosis and hypertension. Lancet. 1994;344(8917):237–9.

    Article  CAS  PubMed  Google Scholar 

  8. Guo H, Kalra PA, Gilbertson DT, et al. Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001. Circulation. 2007;115(1):50–8.

    Article  PubMed  Google Scholar 

  9. van den Dool SW, Wasser MN, de Fijter JW, Hoekstra J, van der Geest RJ. Functional renal volume: quantitative analysis at gadolinium-enhanced MR angiography—feasibility study in healthy potential kidney donors. Radiology. 2005;236(1):189–95.

    Article  PubMed  Google Scholar 

  10. Bakker J, Olree M, Kaatee R, et al. Renal volume measurements: accuracy and repeatability of US compared with that of MR imaging. Radiology. 1999;211(3):623–8.

    Article  CAS  PubMed  Google Scholar 

  11. Coulam CH, Bouley DM, Sommer FG. Measurement of renal volumes with contrast-enhanced MRI. J Magn Reson Imaging. 2002;15(2):174–9.

    Article  PubMed  Google Scholar 

  12. Grobner T. Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006;21(4):1104–8.

    Article  CAS  PubMed  Google Scholar 

  13. Marckmann P, Skov L, Rossen K, Heaf JG, Thomsen HS. Case-control study of gadodiamide-related nephrogenic systemic fibrosis. Nephrol Dial Transplant. 2007;22(11):3174–8.

    Article  CAS  PubMed  Google Scholar 

  14. Commission on Human Medicines. Nephrogenic systemic fibrosis (NSF) with gadolinium-containing magnetic resonance imaging (MRI) contrast agents: update. Medicines and Healthcare Products Regulatory Agency Web site. http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON2030229. Accessed 1 Feb 2010. 26-7-0007. Ref Type: Internet Communication.

  15. Mounier-Vehier C, Cocheteux B, Haulon S, et al. Changes in renal blood flow reserve after angioplasty of renal artery stenosis in hypertensive patients. Kidney Int. 2004;65(1):245–50.

    Article  PubMed  Google Scholar 

  16. Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, de Leeuw PW, van Engelshoven JM. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med. 2001;135(6):401–11.

    Article  CAS  PubMed  Google Scholar 

  17. Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20):1953–62.

    Article  PubMed  Google Scholar 

  18. Cheung CM, Patel A, Shaheen N, et al. The effects of statins on the progression of atherosclerotic renovascular disease. Nephron Clin Pract. 2007;107(2):c35–42.

    Article  CAS  PubMed  Google Scholar 

  19. Treatment of adults and children with renal failure: standards and audit measures. 3rd ed. London: RCP London and the Renal Ass, 2002. 2007. Ref Type: Generic.

    Google Scholar 

  20. Shekelle PG, Rich MW, Morton SC, et al. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol. 2003;41(9):1529–38.

    Article  CAS  PubMed  Google Scholar 

  21. Kalra PA, Guo H, Gilbertson DT, et al. Atherosclerotic renovascular disease in the United States. Kidney Int. 2010;77(1):37–43.

    Article  CAS  PubMed  Google Scholar 

  22. Bloch MJ, Trost DW, Pickering TG, Sos TA, August P. Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement. Am J Hypertens. 1999;12(1 Pt 1):1–7.

    Article  CAS  PubMed  Google Scholar 

  23. Pickering TG, Herman L, Devereux RB, et al. Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet. 1988;2(8610):551–2.

    Article  CAS  PubMed  Google Scholar 

  24. Messina LM, Zelenock GB, Yao KA, Stanley JC. Renal revascularization for recurrent pulmonary edema in patients with poorly controlled hypertension and renal insufficiency: a distinct subgroup of patients with arteriosclerotic renal artery occlusive disease. J Vasc Surg. 1992;15(1):73–80.

    Article  CAS  PubMed  Google Scholar 

  25. Harden PN, MacLeod MJ, Rodger RS, et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet. 1997;349(9059):1133–6.

    Article  CAS  PubMed  Google Scholar 

  26. Scoble JE. Atherosclerotic nephropathy. Kidney Int Suppl. 1999;71:S106–9.

    Article  CAS  PubMed  Google Scholar 

  27. Goldsmith DJ, Reidy J, Scoble J. Renal arterial intervention and angiotensin blockade in atherosclerotic nephropathy. Am J Kidney Dis. 2000;36(4):837–43.

    Article  CAS  PubMed  Google Scholar 

  28. Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370(1):13–22.

    Google Scholar 

  29. Van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999;353(9149):282–6.

    Article  PubMed  Google Scholar 

  30. Iannone LA, Underwood PL, Nath A, Tannenbaum MA, Ghali MG, Clevenger LD. Effect of primary balloon expandable renal artery stents on long-term patency, renal function, and blood pressure in hypertensive and renal insufficient patients with renal artery stenosis. Catheter Cardiovasc Diagn. 1996;37(3):243–50.

    Article  CAS  Google Scholar 

  31. Zeller T, Frank U, Muller C, et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation. 2003;108(18):2244–9.

    Article  PubMed  Google Scholar 

  32. Alhadad A, Ahle M, Ivancev K, Gottsater A, Lindblad B. Percutaneous transluminal renal angioplasty (PTRA) and surgical revascularisation in renovascular disease—a retrospective comparison of results, complications, and mortality. Eur J Vasc Endovasc Surg. 2004;27(2):151–6.

    Article  CAS  PubMed  Google Scholar 

  33. Granillo GA, van Dijk LC, McFadden EP, Serruys PW. Percutaneous radial intervention for complex bilateral renal artery stenosis using paclitaxel eluting stents. Catheter Cardiovasc Interv. 2005;64(1):23–7.

    Article  PubMed  Google Scholar 

  34. Cooper CJ, Haller ST, Colyer W, et al. Embolic protection and platelet inhibition during renal artery stenting. Circulation. 2008;117(21):2752–60.

    Article  CAS  PubMed  Google Scholar 

  35. Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J Vasc Surg. 2003;38(5):962–8.

    Article  PubMed  Google Scholar 

  36. Tan J, Filobbos R, Raghunathan G, et al. Efficacy of renal artery angioplasty and stenting in a solitary functioning kidney. Nephrol Dial Transplant. 2007;22(7):1916–9.

    Article  PubMed  Google Scholar 

  37. Steinbach F, Novick AC, Campbell S, Dykstra D. Long-term survival after surgical revascularization for atherosclerotic renal artery disease. J Urol. 1997;158(1):38–41.

    Article  CAS  PubMed  Google Scholar 

  38. Edwards MS, Craven TE, Burke GL, Dean RH, Hansen KJ. Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch Intern Med. 2005;165(2):207–13.

    Article  PubMed  Google Scholar 

  39. Wright JR, Shurrab AE, Cheung C, et al. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis. 2002;39(6):1153–61.

    Article  PubMed  Google Scholar 

  40. Conlon PJ, Athirakul K, Kovalik E, et al. Survival in renal vascular disease. J Am Soc Nephrol. 1998;9(2):252–6.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Renal Medicine, Salford Royal Hospitals NHS Foundation Trust and University of Manchester, Manchester, UK

    Constantina Chrysochou M.R.C.P. & Philip A. Kalra M.D., F.R.C.P.

Authors
  1. Constantina Chrysochou M.R.C.P.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip A. Kalra M.D., F.R.C.P.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Constantina Chrysochou M.R.C.P. .

Editor information

Editors and Affiliations

  1. Vascular Surgery, Division of Surgery and Cancer, Imperial College, London, United Kingdom

    George Geroulakos

  2. Department of Vascular Surgery, Yale University School of Medicine, New Haven, Connecticut, USA

    Bauer Sumpio

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chrysochou, C., Kalra, P.A. (2018). Renovascular Hypertension. In: Geroulakos, G., Sumpio, B. (eds) Vascular Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-65936-7_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-65936-7_30

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-65935-0

  • Online ISBN: 978-3-319-65936-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation